A phase II study of dexamethasone (Decadron), thalidomide (Thalomid), and Lenalidomide (Revlimid) for subjects with relapsed or refractory multiple myeloma.
Phase of Trial: Phase II
Latest Information Update: 13 Jun 2017
At a glance
- Drugs Dexamethasone (Primary) ; Lenalidomide (Primary) ; Thalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 03 May 2017 Status changed from active, no longer recruiting to discontinued.
- 09 Oct 2007 New trial record.